No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
EIGRQ Eiger BioPharmaceuticals
- 11.200
- +0.050+0.45%
15min DelayClose Jul 3 13:00 ET
16.58MMarket Cap-220P/E (TTM)
11.850High10.900Low13.64KVolume11.000Open11.150Pre Close155.45KTurnover1.60%Turnover RatioLossP/E (Static)1.48MShares28.50052wk High-1.15P/B9.54MFloat Cap1.10052wk Low--Dividend TTM852.06KShs Float12712.500Historical High--Div YieldTTM8.52%Amplitude1.100Historical Low11.396Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Eiger BioPharmaceuticals Issues Cautionary Chapter 11 Reports
Amylyx Inks Deal to Buy Eiger's GLP-1 Targeting Drug
Express News | Eiger BioPharmaceuticals Inc - Asset Purchase Agreement for $35.1 Million, Plus Aggregate Amount of Determined Cure Costs and Assumed Liabilities
Express News | Eiger BioPharmaceuticals Inc - Company and Amylyx Entered Into an Asset Purchase Agreement
Express News | Spruce Biosciences- Agreed to Buy All Rights,Title,Interests in,to & Under Some Assets,Interests Used by Eiger BioPharmaceuticals Related to Avexitide
Eiger BioPharmaceuticals Cautions Investors Amid Bankruptcy
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg